Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record.

A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients: A Clinical, Pharmacokinetic, and Pharmacogenetic Investigation

Baumann, Pierre, Nil, R., Souche, Alain, Montaldi, Stefano, Baettig, Dominique, Lambert, Susanne, Uehlinger, Claude, Kasas, Anton, Amey, Marlyse, Jonzier-Perey, Michele · 1996 · Journal of Clinical Psychopharmacology

Abstract

Sixty-nine depressive patients (DSM III criteria: 296.2, 296.3, 296.5, 300.4) were treated with 40 to 60 mg citalopram (CIT) daily for 4 weeks. Among them, 45 responded to treatment (improvement > 50% on the 21-item Hamilton Rating Scale for Depression [HAM-D]) and continued their treatment for another week before being released from the study. The 24 nonresponders were randomized and comedicated under double-blind conditions with lithium carbonate (Li) (2 x 400 mg/day) (CIT-Li group) or with placebo (CIT-Pl group) from days 29 to 35. For days 36 to 42, the patients of both subgroups were treated openly with Li (800 mg/day) in addition to the ongoing CIT treatment. On day 35, 6 of 10 patients responded to the CIT-Li combination, whereas 2 of 14 patients only responded to the CIT-Pl combination. This group difference reached significance (p < 0.05) on day 35 with lower HAM-D total scores in the CIT-Li group. No evidence was seen of a pharmacokinetic interaction between CIT and Li, and this combination was well tolerated. Patients were phenotyped with dextromethorphan and mephenytoin at baseline and at day 28. As evaluated at baseline, three patients (responders) were poor metabolizers of dextromethorphan and six patients (three responders and three nonresponders) of mephenytoin. On day 28, the ratio CIT/N-desmethylCIT (DCIT) in plasma was significantly higher in poor than in extensive metabolizers of mephenytoin (p = 0.0001), and there was a significant positive correlation between the metabolic ratio of dextromethorphan and the ratio DCIT/N-didesmethylCIT in plasma (p < 0.001). These findings illustrate the role of CYP2D6 and CYP2C19 in the metabolism of CIT. It can be concluded that Li addition to CIT is effective in patients not responding to CIT alone without any evidence of an accentuation or provocation of adverse events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199608000-00006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 39

  1. de Montigny, 1981, Br J Psychiatry, 138, 252, 10.1192/bjp.138.3.252 · DOI · Paper page
  2. Schopf, 1989, Pharmacopsychiatry, 22, 174, 10.1055/s-2007-1014602 · doi:10.1055/s-2007-1014602
  3. Austin, 1991, Br J Psychiatry, 159, 510, 10.1192/bjp.159.4.510 · DOI
  4. Delgado, 1988, J Affect Disord, 15, 55, 10.1016/0165-0327(88)90009-2 · DOI
  5. Ontiveros, 1991, Acta Psychiatr Scand, 83, 188, 10.1111/j.1600-0447.1991.tb05522.x · DOI
  6. Kuroda, 1994, Eur J Pharmacol (Molecular Pharmacology Section), 268, R3, 10.1016/0922-4106(94)90127-9 · DOI
  7. Fava, 1994, Am J Psychiatry, 151, 1372, 10.1176/ajp.151.9.1372 · DOI · Paper page
  8. Katona, 1995, Br J Psychiatry, 166, 80, 10.1192/bjp.166.1.80 · DOI · Paper page
  9. Hawley, 1994, J Psychopharmacol, 8, 266, 10.1177/026988119400800412 · DOI
  10. Dinah, 1993, Acta Psychiatr Scand, 88, 300, 10.1111/j.1600-0447.1993.tb03461.x · doi:10.1111/j.1600-0447.1993.tb03461.x
  11. Cowen, 1991, Br J Psychiatry, 159, 341, 10.1192/bjp.159.3.341 · DOI
  12. McCance-Katz, 1992, Psychopharmacology, 108, 93, 10.1007/BF02245291 · DOI
  13. Nixon, 1994, Psychopharmacology, 115, 59, 10.1007/BF02244752 · DOI
  14. Hyttel, 1982, Prog Neuropsychopharmacol Biol Psychiatry, 6, 277, 10.1016/S0278-5846(82)80179-6 · DOI · Paper page
  15. Milne, 1991, Drugs, 41, 450, 10.2165/00003495-199141030-00008 · DOI · Paper page
  16. Luo, 1993, Int Clin Psychopharmacol, 8, 3, 10.1097/00004850-199300810-00001 · DOI
  17. Uehlinger, 1995, Int J Geriatr Psychiatry, 10, 281, 10.1002/gps.930100404 · DOI
  18. Oyehaug, 1984, J Chromatogr Biomed Appl, 308, 199, 10.1016/0378-4347(84)80209-1 · DOI
  19. Sindrop, 1993, Ther Drug Monit, 15, 11, 10.1097/00007691-199302000-00002 · DOI · Paper page
  20. Daly, 1993, Pharmacol Ther, 57, 129, 10.1016/0163-7258(93)90053-G · DOI · Paper page
  21. Spina, 1994, Pharmacol Res, 29, 121, 10.1016/1043-6618(94)80036-7 · doi:10.1016/1043-6618(94)80036-7
  22. Gorski, 1994, Biochem Pharmacol, 48, 173, 10.1016/0006-2952(94)90237-2 · DOI
  23. Souche, 1991, Encephale, XVII, 213
  24. Hamilton, 1967, Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
  25. Noveske, 1989, Am J Psychiatry, 146, 1515
  26. Schopf, 1989, Pharmacopsychiatry, 22, 183, 10.1055/s-2007-1014603 · DOI
  27. Lingjaerde, 1987, Acta Psychiatr Scand, 334, 81
  28. Reymond, 1993, J Chromatogr Biomed Appl, 616, 221, 10.1016/0378-4347(93)80389-L · DOI
  29. Baumann, 1992, Ther Drug Monit, 14, 1, 10.1097/00007691-199202000-00001 · doi:10.1097/00007691-199202000-00001
  30. Zhang, 1991, Br J Clin Pharmacol, 31, 350, 10.1111/j.1365-2125.1991.tb05542.x · doi:10.1111/j.1365-2125.1991.tb05542.x
  31. Pope, 1988, Am J Psychiatry, 145, 1292, 10.1176/ajp.145.10.1292 · doi:10.1176/ajp.145.10.1292
  32. Ohman, 1993, Pharmacopsychiatry, 26, 263, 10.1055/s-2007-1014367 · doi:10.1055/s-2007-1014367
  33. Salama, 1989, Am J Psychiatry, 146, 278
  34. Steinbach, 1991, Am J Psychiatry, 148, 705, 10.1176/ajp.148.6.705 · DOI · Paper page
  35. Brady, 1991, J Clin Psychiatry, 52, 509
  36. Baumann, 1995, Rev Contemp Pharmacother, 6, 287
  37. Gram, 1993, Ther Drug Monit, 15, 18, 10.1097/00007691-199302000-00003 · DOI
  38. Brosen, 1993, Clin Investig, 71, 1002, 10.1007/BF00180032 · doi:10.1007/bf00180032
  39. Coutts, 1994, J Pharmacol Toxicol Methods, 31, 177, 10.1016/1056-8719(94)90001-9 · DOI

Cited by

See all 173

Metadata

Authors
Baumann, P., Nil, R., Souche, A., Montaldi, S., Baettig, D., Lambert, S., Uehlinger, C., Kasas, A., Amey, M., & Jonzier-Perey, M.
Venue
Journal of Clinical Psychopharmacology
Published
1996-08
Volume
16
Issue
4
Pages
307-314
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2083597120
Cited by
173
References
0
FWCI
6.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients: A Clinical, Pharmacokinetic, and Pharmacogenetic Investigation. https://app.cochat.ai/papers/10.1097/00004714-199608000-00006
The paper
Baumann, P., Nil, R., Souche, A., Montaldi, S., Baettig, D., Lambert, S., Uehlinger, C., Kasas, A., Amey, M., & Jonzier-Perey, M. (1996). A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients: A Clinical, Pharmacokinetic, and Pharmacogenetic Investigation. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199608000-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.